Triple-negative breast cancer (TNBC) is a type of breast cancer with the absence of three common receptors found on many breast cancer cells. These are estrogen receptors, progesterone receptors, and the HER2 protein. Because these receptors are absent, hormone therapies and HER2-targeted treatments are ineffective for TNBC.
Breast cancer begins when abnormal cells grow uncontrollably in the breast tissue. The breast is made up of lobules, ducts, fatty tissue, and connective tissue. Triple-negative breast cancer often develops in the ducts and is considered an invasive form of breast cancer, meaning it can spread into surrounding breast tissue if not treated.
Although TNBC is less common than other breast cancer subtypes, effective treatment options are available at Tucson Breast Health Specialists, especially when diagnosed early.
Risk Factors for Triple-Negative Breast Cancer
Anyone can develop triple-negative breast cancer, but certain factors are associated with a higher likelihood of diagnosis. TNBC is more commonly seen in younger patients and in those with inherited genetic mutations, particularly BRCA1/2. It is also diagnosed at higher rates in some ethnic populations.
Having risk factors does not mean you will develop TNBC, and many patients diagnosed with this condition have no known risk factors. Regular breast screening and prompt evaluation of breast changes are essential for early detection.
How Is Triple-Negative Breast Cancer Diagnosed?
Diagnosis usually begins with breast imaging, such as a mammogram, ultrasound, or breast MRI, followed by a biopsy. During the biopsy, a small sample of tissue is examined to confirm cancer and determine receptor status. If triple-negative breast cancer is diagnosed, additional testing may be performed to assess lymph nodes or the body to determine whether the cancer has spread. This staging process helps guide treatment recommendations and surgical planning.
Triple-Negative Breast Cancer Treatment Options
Lumpectomy
A lumpectomy formally called partial mastectomy removes the tumor along with a small margin of surrounding healthy tissue while preserving most of the breast. This option is usually followed by radiation therapy.
Mastectomy
A mastectomy involves the removal of the entire breast and may be recommended for larger tumors, multiple areas of cancer, or based on genetic risk factors or patient preference.
Oncoplastic Breast Surgery
Oncoplastic breast surgery combines cancer removal with reconstructive techniques to help maintain or improve breast shape after surgery.
Lymph Node Surgery
Lymph node surgery helps determine whether cancer has spread beyond the breast. This may include a sentinel lymph node biopsy or the removal of additional lymph nodes, as indicated.
Chemotherapy
Many patients with triple-negative breast cancer also receive chemotherapy, either before surgery (neoadjuvant) or after surgery (adjuvant), as part of their comprehensive treatment plan.
Contact Us
If you have been diagnosed with triple-negative breast cancer or need further evaluation for a breast concern, we encourage you to reach out to our team. Please contact Dr. Michele Ley at Tucson Breast Health Specialists to schedule a consultation and learn more about your treatment and surgical options. We are here to support you with expert, compassionate care at every step.
Board-Certified Surgeon
MICHELE LEY, MD, FACS
Dr. Ley, a breast surgical oncologist in Tucson since 2006, delivers compassionate and personalized care to create tailored treatment plans based on the latest research. Specializing in surgical care for breast cancer and high-risk patients, she employs minimally invasive techniques and practices oncoplastic surgery to optimize outcomes.
More About Dr. Ley“The level of care is excellent.”
ABOUT US
More About Us
OUR BLOG
Read Our BlogCONTACT US
We are dedicated to providing the support you need. Contact us today to learn more about how we can help on your breast health journey.
We are only accepting patients with surgical breast diseases. We do not see patients for breast pain or without imaging in the last three months. If you have been diagnosed with one of the following, please submit the contact form or call our office at (520) 605-2778 to schedule your appointment.
- Breast cancer, DCIS (ductal carcinoma in situ), LCIS (lobular carcinoma in situ), invasive ductal carcinoma, invasive lobular carcinoma, and any other breast malignancies such as sarcoma, and malignant phyllodes
- Patients with known genetic mutations such as BRCA 1, 2, and others
- Fibroadenoma, phyllodes tumor, radial scar, complex sclerosing lesion, papilloma >8mm, atypical papilloma, nipple mass or ulceration,
- Granulomatous mastitis
- Atypical ductal or lobular hyperplasia ( ALH, ADH), and any benign lesion with atypia

